Held, J.; Esse, J.; Tascilar, K.; Steininger, P.; Schober, K.; Irrgang, P.; Alsalameh, R.; Tenbusch, M.; Seggewies, C.; Bogdan, C.
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®). Vaccines 2021, 9, 1063.
https://doi.org/10.3390/vaccines9101063
AMA Style
Held J, Esse J, Tascilar K, Steininger P, Schober K, Irrgang P, Alsalameh R, Tenbusch M, Seggewies C, Bogdan C.
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®). Vaccines. 2021; 9(10):1063.
https://doi.org/10.3390/vaccines9101063
Chicago/Turabian Style
Held, Jürgen, Jan Esse, Koray Tascilar, Philipp Steininger, Kilian Schober, Pascal Irrgang, Rayya Alsalameh, Matthias Tenbusch, Christof Seggewies, and Christian Bogdan.
2021. "Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®)" Vaccines 9, no. 10: 1063.
https://doi.org/10.3390/vaccines9101063
APA Style
Held, J., Esse, J., Tascilar, K., Steininger, P., Schober, K., Irrgang, P., Alsalameh, R., Tenbusch, M., Seggewies, C., & Bogdan, C.
(2021). Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®). Vaccines, 9(10), 1063.
https://doi.org/10.3390/vaccines9101063